Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2022-12-02 00:00:00 ET · period of report 2022-11-30 · accession 0001104659-22-124100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-02 | 2022-11-30 | FBIO | Jin David | CFO | P - Purchase | $0.56 | +5,000 | 1.40M | +0.4% | +$2,800 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2022-11-30 | P | A | 5,000 | $0.56 | 1,402,829 | D | — | — | (F1) Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period. Under the ESPP, 5,000 shares is the maximum amount an individual employee may purchase during an offering period. (F2) The total holdings include 1,350,000 shares underlying restricted stock units. |